| ID | 545 |
|---|
| No | 545 |
|---|
| Brand Name | OGIVRI 150 |
|---|
| Ingredients | TRASTUZUMAB 150 MG |
|---|
| Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 4 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL/150 MG |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | ADJUVANT BREAST CANCER, MATASTATIC BREAST CANCER, METASTATIC GASTRIC CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | STERILE, OFF WHITE TO PALE YELLOW, PRESERVATIVE-FREE LYOPHILIZED POWDER FOR INJECTION, FOR INTRAVENOUS ADMINISTRATION |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | BIOCON LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 I 5439/23 |
|---|
| FDD Registration Date | 31/03/2023 |
|---|
| Expiry Date | 30/03/2026 |
|---|
